Christian Weißenberger

Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma

Christine Dierks, Jochen Seufert, Konrad Aumann et al. · Thyroid · 2021 · 245 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Do Erythropoietin Receptors on Cancer Cells Explain Unexpected Clinical Findings?

Michael Henke, Dominik Mattern, Margaret S. Pepe et al. · Journal of Clinical Oncology · 2006 · 241 citations · Full text

Medicine, Oncology, Pharmacology +17

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

Petra Seibold, Adam Webb, Miguel E. Aguado‐Barrera et al. · Radiotherapy and Oncology · 2019 · 96 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Dominant Role of Prostaglandin E2 EP4 Receptor in Furosemide-Induced Salt-Losing Tubulopathy

Rolf M. NuCombining Diaeresissing, Antje Treude, Christian Weißenberger et al. · Journal of the American Society of Nephrology · 2005 · 54 citations

Medicine, Nephrology, Pharmacology +17

The proteasome inhibitor MG-132 sensitizes PC-3 prostate cancer cells to ionizing radiation by a DNA-PK-independent mechanism

Frank Pajonk, Arndt van Ophoven, Christian Weißenberger et al. · BMC Cancer · 2005 · 44 citations · Full text

Medicine, Oncology, Pharmacology +17